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Objective. Synovial fi broblasts (SFs) contribute to the development of osteoarthritis 
(OA) by the secretion of a wide range of pro-inﬂ ammatory mediators, including cytokines 
and lipid mediators of inﬂ ammation (1). Previous studies show that electromagnetic fi elds 
(EMFs) may represent a potential therapeutical approach to limit cartilage degradation 
and to control inﬂ ammation associated to OA, and that they may act through the aden-
osine pathway (2). On this basis the aim of this study was to investigate if EMFs might 
modulate inﬂ ammatory activities of human SFs derived from OA patients (OASFs) and 
the possible involvement of adenosine receptors (ARs) in mediating EMF eff ects.
Design. SFs obtained from OA patients, undergoing total hip joint replacement 
surgery, were exposed to EMFs (1.5 mT; 75 Hz) for 24 hours. In control and EMF-
exposed cells, ARs were evaluated by western blotting, quantitative real-time RT-
PCR and saturation binding experiments and cAMP levels were measured by a spe-
cifi c assay. In the absence and in the presence of interleukin-1β (IL-1β), used as a 
pro-inﬂ ammatory stimulus, prostaglandin E2 (PGE2), cytokine and matrix degrading 
enzyme production was evaluated in OASFs exposed to EMFs and treated with selec-
tive adenosine receptor agonists and antagonists.
Results. EMF exposure induced a selective increase in A2A and A3 ARs. These 
increases were associated to changes in cAMP levels, indicating that ARs were 
functionally active in EMF-exposed cells. In IL-1β-treated OASFs, functional data 
obtained in the presence of  A2A and A3 adenosine agonists and antagonists showed 
that EMFs inhibit the release of (PGE2) and of the proinﬂ ammatory cytokines inter-
leukin-6 (IL-6) and interleukin-8 (IL-8), whilst stimulate the release of interleukin-10 
(IL-10), an antinﬂ ammatory cytokine. Further, results show that these eff ects appear 
to be mediated by the EMF-induced upregulation of A2A and A3 ARs. No eff ects of 
EMFs or ARs have been observed on matrix degrading enzymes production.
Conclusions: EMFs display anti-inﬂ ammatory eff ects in human OASFs and these 
EMF-induced .ff ects are in part mediated by the adenosine pathway, specifi cally by 
the A2A and A3 ARs activation. Taken together, these results suggest that SFs could 
represent potential therapeutic targets cells for EMF treatment and open new clinical 
perspectives to the control of inﬂ ammation associated to joint diseases.
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